novo nordisk lawsuits against compounding pharmacies semaglutide 2023 2024 2025 A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Defending Against Pharma Trademark Suits

A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last Weight Watchers launches a fully integrated platform for the GLP-1 era NEW YORK, Dec

Glutathione does this by donating an electron to the free radical, making it stable

26 Certain GLP-1 agonist drugs have been associated with a significantly increased risk of depression and anxiety, 27 highlighting an emerging need for complimentary therapies to support patients mental and emotional health while undergoing pharmaceutical GLP-1 therapy

doi: 10.1126/science.1241165 90 SpaggiariG.BriganteG.De VincentisS.CattiniU.RoliL.De SantisM